|
C. difficile Toxin B (8-16)
|
GLN-LEU-GLU-LYS-MET-ALA-ASN-VAL-ARG
|
|
|
TNF-α (72-82), human
|
H-PRO-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-OH
|
|
|
C. difficile Toxin B (248-262)
|
ASN-GLY-GLU-SER-PHE-ASN-LEU-TYR-GLU-GLN-GLU-LEU-VAL-GLU-ARG
|
|
|
TNF-α(78-96) (human)
|
H-HIS-THR-ILE-SER-ARG-ILE-ALA-VAL-SER-TYR-GLN-THR-LYS-VAL-ASN-LEU-LEU-SER-ALA-OH
|
|
|
C. difficile Toxin B (529-536)
|
ALA-GLN-PHE-GLU-GLU-TYR-LYS-ARG
|
|
|
SRC Kinase Substrate, amide
|
ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-PTYR-ALA-ALA-ARG-GLY-NH2
|
|
|
Prepro TRH (83-106)
|
GLU-GLU-GLU-GLU-LYS-ASP-ILE-GLU-ALA-GLU-GLU-ARG-GLY-ASP-LEU-GLY-GLU-GLY-GLY-ALA-TRP-ARG-LEU-HIS
|
|
|
P55-TNFR
|
LEU-PRO-GLN-ILE-GLU-ASN-VAL-LYS-GLY-THR-GLU-ASP
|
|
|
MARCKS PSD-Derived Peptide, PKC Substrate
|
LYS-LYS-ARG-PHE-SER-PHE-LYS-LYS-SER-PHE-LYS-LEU
|
|
|
C. difficile Toxin B (392-401)
|
ASP-SER-TYR-CYS-SER-ASN-LEU-ILE-VAL-LYS
|
|
|
C. difficile Toxin B (232-241)
|
ILE-THR-GLN-ASN-SER-GLY-ASN-ASP-VAL-ARG
|
|
|
Prepro TRH (160-169)
|
SER-PHE-PRO-TRP-MET-GLU-SER-ASP-VAL-THR
|
|
|
Boc-Phe-Ala-Ala-Gly-Arg-Lys-AMC
|
BOC-PHE-ALA-ALA-GLY-ARG-LYS-AMC
|
|
|
Ac-Ile-Glu-Gly-Arg-pNA
|
|
|
|
Pyr-Gly-Arg-pNA
|
PYR-GLY-ARG-PNA
|
|
|
D-Phe7, D-Trp10]-Somatostatin 14 (7-14)
|
D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR (DISULFIDE BRIDGE: CYS2-CYS7)
|
|
|
Ac-Ile-Glu-Ala-Arg-pNA
|
AC-ILE-GLU-ALA-ARG-PNA
|
|
|
Boc-Arg-Arg-Arg-AMC
|
BOC-ARG-ARG-ARG-AMC
|
|
|
Ac-Gly-Pro-Lys-pNA
|
AC-GLY-PRO-LYS-PNA
|
|
|
Suc-Ala-Pro-Ala-pNA
|
SUC-ALA-PRO-ALA-PNA
|
72682-79-2
|
|
H-Met-Gly-Pro-pNA
|
H-MET-GLY-PRO-PNA
|
|
|
Boc-Pro-Arg-Arg-AMC
|
BOC-PRO-ARG-ARG-AMC
|
|
|
PKG Substrate
|
GLN-LYS-ARG-PRO-ARG-ARG-LYS-ASP-THR-PRO
|
|
|
Human CMV Assemblin Protease Substrate (M-site)
|
ARG-GLY-VAL-VAL-ASN-ALA-SER-SER-ARG-LEU-ALA-LYS
|
|
|
MMP-3 Substrate I, fluorogenic
|
DNP-PRO-TYR-ALA-TYR-TRP-MET-ARG
|
|
|
Suc-Ser-Asp-Pro-Phe-pNA
|
SUE-SER-ASP-PRO-PHE-PNA
|
|
|
GSK3 Peptide Substrate
|
GLY-ARG-PRO-ARG-THR-THR-SER-PHE-ALA-GLU
|
|
|
Suc-Leu-Glu-Pro-Phe-pNA
|
SUC-LEU-GLU-PRO-PHE-PNA
|
|
|
Transglutaminase Substrate, biotinylated
|
BIOTIN-THR-VAL-GLN-GLN-GLU-LEU
|
|
|
Casein Kinase II Substrate
|
ARG-ARG-ARG-GLU-GLU-GLU-THR-GLU-GLU-GLU
|
|
|
MMP-1 Substrate I, fluorogenic
|
DNP-PRO-LEU-ALA-LEU-TRP-ALA-ARGDNP-PRO-LEU-GLY-MET-TRP-SER-ARGCYS-THR-THR-HIS-TRP-GLY-PHE-THR-LEU-CYS
|
135662-04-3
|
|
Ile76]-TNF-a (70-80) (human)
|
PRO-SER-THR-HIS-VAL-LEU-ILE-THR-HIS-THR-ILE
|
|
|
Caspase 1 Substrate 1 (ICE), chromogenic
|
AC-TYR-GLU-VAL-ASP-PNA
|
|
|
N(p-Tosyl)-Gly-Pro-Arg-pNA
|
N(P-TOSYL)-GLY-PRO-ARG-PNA
|
|
|
SIVmac239-1
|
MET-GLY-VAL-ARG-ASN-SER-VAL-LEU-SER-GLY-LYS-LYS-ALA-ASP-GLU
|
|
|
SIVmac239-2
|
ASN-SER-VAL-LEU-SER-GLY-LYS-LYS-ALA-ASP-GLU-LEU-GLU-LYS-ILE
|
|
|
Nocistatin
|
GLU-GLN-LYS-GLN-LEU-GLN
|
|
|
TAT
|
H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-NH2
|
|
|
Nuclear Export Signal, NES, Dok-1 (348-359)
|
LEU-LEU-LYS-ALA-LYS-LEU-THR-ASP-PRO-LYS-GLU-ASP
|
|
|
HPV16-E711-20 epitope
|
HPV16-E711-20 epitope
|
160040-04-0
|
|
Difelikefalin (CR845)
|
CR 845
|
1024828-77-0
|
|
Gly6
|
H-GLY-GLY-GLY-GLY-GLY-GLY-OH
|
3887-13-6
|
|
CyclosporinA-Derivative2
|
環(huán)孢菌素A-衍生物2
|
156047-45-9
|
|
D-γ-Glutamyl-D-glutamicacid
|
D-γ-Glutamyl-D-glutamic acid
|
4553-17-7
|
|
Pam2CSK4
|
Pam2CSK4
|
868247-72-7
|
|
ALX40-4C
|
ALX 40-4C
|
143413-49-4
|
|
Rac1InhibitorW56
|
RAC1 INHIBITOR W56
|
1095179-01-3
|
|
Oligopeptide P11-4
|
Oligopeptide P11-4
|
593266-60-5
|
|
RC-3095
|
NULL
|
138147-78-1
|
|
MARCKS Peptide(151-175), Phosphorylated
|
H-LYS-LYS-LYS-LYS-LYS-ARG-PHE-{PSER}-PHE-LYS-LYS-{PSER}-PHE-LYS-LEU-SER-GLY-PHE-{PSER}-PHE-LYS-LYS-ASN-LYS-LYS-OH
|
|
|
Ac-Orn-OH
|
(S)-2-乙酰氨基-5-氨基戊酸
|
6205-08-9
|
|
DX600 TFA
|
AC-GLY-ASP-TYR-SER-HIS-CYS-SER-PRO-LEU-ARG-TYR-PRO-TRP-LYS-CYS-THR-TYR-PRO-ASP-PRO-GLU-GLY-GLY-GLY-NH2
|
|
|
Huwentoxin XVI
|
H-CYS-ILE-GLY-GLU-GLY-VAL-PRO-CYS-ASP-GLU-ASN-ASP-PRO-ARG-CYS-CYS-SER-GLY-LEU-VAL-CYS-LEU-LYS-PRO-THR-LEU-HIS-GLY-ILE-TRP-TYR-LYS-SER-TYR-TYR-CYS-TYR-LYS-LYS-OH(DISULFIDE BRIDGE:CYS1-CYS16;CYS8-CYS21;CYS15-CYS36)
|
1600543-88-1
|
|
Lys-Lys dihydrochloride
|
L-賴氨酰-L-賴氨酸二鹽酸鹽
|
52123-30-5
|
|
YAP-TEAD-IN-1
|
YAP-TEAD Inhibitor 1
|
1659305-78-8
|
|
p5 Ligand for Dnak and DnaJ
|
P5 LIGAND FOR DNAK AND DNAJ
|
209518-24-1
|
|
N-Acetyl-O-phosphono-Tyr-GluDipentylamide
|
AC-TYR(PO3H2)-GLU-DIPENTYLAMIDE
|
190078-50-3
|
|
Pam3CSK4
|
PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH
|
112208-00-1
|
|
JAG-1,scrambled
|
JAG-1, scrambled
|
402941-23-5
|
|
H-Cys-Gly-Gly-Arg-Gly-Asp-OH
|
|
1260223-44-6
|
|
PL017
|
N-Me-phe（3）-嗎啡肽
|
83397-56-2
|
|
Tyroserleutide hydrochloride
|
Tyr-Ser-Leu
|
852982-42-4
|
|
CyclosporinA-Derivative1
|
1487360-85-9
|
1487360-85-9
|
|
TAT-GluA23Y
|
H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-TYR-LYS-GLU-GLY-TYR-ASN-VAL-TYR-GLY-OH
|
1404188-93-7
|
|
Ac-Val-Asp-Ile-Asp-OH
|
|
|
|
AdTx1
|
H-LEU-THR-CYS-VAL-THR-SER-LYS-SER-ILE-PHE-GLY-ILE-THR-THR-GLU-ASP-CYS-PRO-ASP-GLY-GLN-ASN-LEU-CYS-PHE-LYS-ARG-ARG-HIS-TYR-VAL-VAL-PRO-LYS-ILE-TYR-ASP-SER-THR-ARG-GLY-CYS-ALA-ALA-THR-CYS-PRO-ILE-PRO-GLU-ASN-TYR-ASP-SER-ILE-HIS-CYS-CYS-LYS-THR-ASP-LYS-CYS-ASN-GLU-OH(DISULFIDE BRIDGE:CYS3-CYS24;CYS17-C
|
|
|
N-Acetyl epitalamide amidate
|
AC-ALA-GLU-ASP-GLY-NH2
|
|
|
Ac-Ile-Glu-Val-Asp-Ile-Asp-Val-OH
|
|
|
|
ADWX1
|
H-VAL-GLY-ILE-ASN-VAL-LYS-CYS-LYS-HIS-SER-ARG-GLN-CYS-LEU-LYS-PRO-CYS-LYS-ASP-ALA-GLY-MET-ARG-PHE-GLY-LYS-CYS-THR-ASN-GLY-LYS-CYS-HIS-CYS-THR-PRO-LYS-OH(DISULFIDE BRIDGE: 7-27, 13-32, 17-34)
|
|
|
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm
|
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm
|
1647119-71-8
|
|
Ac-Ile-Glu-Val-Asp-Ile-Asp-OH
|
|
|
|
SIYRY
|
SIYRY
|
178561-37-0
|
|
PGLa
|
PGLA
|
102068-15-5
|
|
Hsp70-derivedoctapeptide
|
HSP70-DERIVED OCTAPEPTIDE
|
736171-62-3
|
|
Ac-Semax Acetate
|
AC-MET-GLU-HIS-PHE-PRO-GLY-PRO-OH
|
|
|
AmmTX3
|
PYR-ILE-GLU-THR-ASN-LYS-LYS-CYS-GLN-GLY-GLY-SER-CYS-ALA-SER-VAL-CYS-ARG-LYS-VAL-ILE-GLY-VAL-ALA-ALA-GLY-LYS-CYS-ILE-ASN-GLY-ARG-CYS-VAL-CYS-TYR-PRO-OH(DISULFIDE BRIDGE:CYS8-CYS28;CYS13-CYS33;CYS17-CYS35)
|
|
|
Tyr12]-Somatostatin-28 (1-14)
|
(TYR12)-SOMATOSTATIN-28 (1-14)
|
|
|
Biotin-(Leu8,D-Trp22,Tyr25)-Somatostatin-28
|
BIOTIN-SER-ALA-ASN-SER-ASN-PRO-ALA-LEU-ALA-PRO-ARG-GLU-ARG-LYS-ALA-GLY-CYS-LYS-ASN-PHE-PHE-D-TRP-LYS-THR-TYR-THR-SER-CYS (DISULFIDE BRIDGE:CYS17-CYS28)
|
|
|
Somatostatin Tumor Inhibiting Analog
|
D-Β-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2 (DISULFIDE BRIDGE:CYS2-CYS7 )
|
|
|
Ac-Gly-Pro-Lys(Ac)-pNA
|
|
|
|
cAC253
|
H-CYS-LEU-GLY-ARG-LEU-SER-GLN-GLU-LEU-HIS-ARG-LEU-GLN-THR-TYR-PRO-ARG-THR-ASN-THR-GLY-SER-ASN-THR-TYR-CYS-NH2(DISULFIDE BRIDGE:CYS1-CYS26)
|
|
|
GR64349
|
H-LYS-ASP-SER-PHE-VAL-GLY-R-GAMMA-LACTAM-LEU-MET-NH2
|
137593-52-3
|
|
ProTxIII
|
H-ASP-CYS-LEU-LYS-PHE-GLY-TRP-LYS-CYS-ASN-PRO-ARG-ASN-ASP-LYS-CYS-CYS-SER-GLY-LEU-LYS-CYS-GLY-SER-ASN-HIS-ASN-TRP-CYS-LYS-LEU-HIS-ILE-NH2(DISULFIDE BRIDGE:CYS2-CYS17;CYS9-CYS22;CYS16-CYS29)
|
|
|
Ac-Ile-Glu-Val-Asp-Ile-Asp-Val-Glu-His-OH
|
|
|
|
Cortagine
|
PYR-GLY-PRO-PRO-ILE-SER-ILE-ASP-LEU-SER-LEU-GLU-LEU-LEU-ARG-GLU-VAL-LEU-GLU-MET-GLU-ARG-ALA-GLU-GLN-LEU-ALA-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ALA-NH2
|
|
|
Tertiapin-Q
|
TERTIAPIN-Q
|
252198-49-5
|
|
D-Ser13]-Somatostatin-14
|
(D-SER13)-SOMATOSTATIN-14
|
|
|
CyclosporinD
|
環(huán)孢霉素D
|
63775-96-2
|
|
Tetraglycine
|
四聚甘胺酸
|
637-84-3
|
|
C21
|
AC-SER-GLY-N5-(2-CHLORO-1-IMINOETHYL)]-ORN)-GLY-LYS-GLY-GLY-LYS-GLY-LEU-GLY-LYS-GLY-GLY-ALA-LYS-ARG-HIS-ARG-LYS-VAL
|
1229236-78-5
|
|
BDNF(human)
|
REC BRAIN-DERIVED NEUROTROPHIC FACTOR (HUMAN)
|
218441-99-7
|
|
Somatostatin-14 (2-9)
|
GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS
|
|
|
Ac-Ile-Glu-Val-Asp-Ile-Asp-Val-Glu-OH
|
|
|
|
Obtustatin
|
H-CYS-THR-THR-GLY-PRO-CYS-CYS-ARG-GLN-CYS-LYS-LEU-LYS-PRO-ALA-GLY-THR-THR-CYS-TRP-LYS-THR-SER-LEU-THR-SER-HIS-TYR-CYS-THR-GLY-LYS-SER-CYS-ASP-CYS-PRO-LEU-TYR-PRO-GLY-OH(DISULFIDE BRIDGE:CYS1-CYS10;CYS6-CYS29;CYS7-CYS34;CYS19-CYS36)
|
|
|
SV40 T-Ag-derived NLS peptide
|
PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLU-ASP-*PRO-TYR-CYS
|
105425-98-7
|
|
H-Beta-Ala-Tyr-OH
|
|
21612-26-0
|
|
Transforming Growth Factor β1 Peptide, TGF - β1 (60 - 66), amide
|
H-LYS-VAL-LEU-ALA-LEU-TYR-ASN-LYS-NH2
|
|
|
MMP Biotinylated Substrate I
|
BIOTIN-LC-PRO-LEU-GLY-LEU-ARG-ALA-TYR-NH2
|
|
|
OVAG4peptide
|
H-SER-ILE-ILE-GLY-PHE-GLU-LYS-LEU-OH
|
148274-82-2
|
|
Suc-Arg-Gly-Pro-Phe-pNA
|
SUC-ARG-GLY-PRO-PHE-PNA
|
|